Control Changes Hands: 64.26% Stake Transferred to Indo Borax, Full Board and KMP Overhaul
Big change of control.
- Stake Transferred
- 2,38,44,000 equity shares — 64.26% of paid-up capital
- Transfer Date
- September 29, 2026
- Buyer
- Indo Borax & Chemicals Limited
- New MD & CEO
- Suresh Kalra (5 years)
- New CFO
- Shashikant Bharuka (5 years)
What happened
The share purchase agreement dated August 20, 2026 has been completed. On September 29, 2026 the sellers — Mr. Ketan Vinodchandra Ramani, Mr. Pritesh Vinodchandra Ramani and Mr. Jogindersingh Gianchand Jaswal — transferred 2,38,44,000 equity shares, constituting 64.26% of the total paid-up equity share capital, to the purchaser, Indo Borax & Chemicals Limited. Zenrock Chemicals Private Limited was also a party to the SPA.
After the sale, the sellers collectively hold 36,90,000 equity shares, or 9.95% of the voting share capital, and each of them along with other promoter group members has ceased to be part of the promoter/promoter group.
New leadership
- Mr. Suresh Kalra appointed additional director (Managing Director and Chief Executive Officer) for 5 years from September 29, 2026, subject to member approval. He has over 25 years of leadership experience in the chemicals industry, including CEO and Whole-time Director at Aquapharm Chemical Limited and senior roles at Huber group, SI Group, Pidilite Industries, Valvoline Cummins and W.R. Grace.
- Mr. Sunil Malhotra appointed additional director (executive, non-independent) and Whole-time Director for 5 years, liable to retire by rotation. He has 38 years of experience as an entrepreneur and investor.
- Mr. Harsh Malhotra appointed additional director (executive, non-independent) for 5 years, liable to retire by rotation. He is the son of Mr. Sunil Malhotra and brings over a decade of global operational experience, including nearly ten years at Amazon.
- Three new independent directors for 5 years each: Mr. Amit Kumar Sharma, Ms. Anuradha Suneet Maheshwari and Mr. Dhananjay Tapasvi.
- Mr. Shashikant Bharuka appointed Chief Financial Officer and Key Managerial Personnel for a term of 5 years.
Exits
- Mr. Jogindersingh Gianchand Jaswal resigned as Managing Director, effective immediately on delivery of his resignation letter.
- Mr. Ketan Ramani and Mr. Pritesh Vinodchandra Ramani resigned as executive directors, effective immediately.
- Mr. Samir Gadhiya resigned as Chief Financial Officer, effective immediately.
- Independent directors Mr. Parth Shah, Ms. Krutika Arunkumar Negandhi and Mr. Satish Kumar resigned with effect from the close of business on September 29, 2026.
Committees reconstituted
The Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee and Corporate Social Responsibility Committee were all reconstituted with effect from September 29, 2026. The Audit Committee is now chaired by Mr. Dhananjay Tapasvi with Mr. Suresh Kalra and Mr. Amit Kumar Sharma as members. The NRC comprises Mr. Dhananjay Tapasvi (Chairman), Mr. Amit Kumar Sharma and Ms. Anuradha Suneet Maheshwari. The Stakeholders Relationship Committee is chaired by Ms. Anuradha Suneet Maheshwari. The CSR Committee is chaired by Mr. Suresh Kalra.
Continuity arrangement
The board approved execution of consultancy agreements with each of Mr. Jogindersingh Gianchand Jaswal, Mr. Ketan Ramani and Mr. Pritesh Vinodchandra Ramani — the three exiting founders — so they can continue to be associated in an advisory capacity.
Why it matters for investors
A change in controlling shareholder of this size means the company's strategic direction, management team and board now sit with a new owner group. The founders retain a residual 9.95% holding but no longer form the promoter group. The new appointments as additional directors require approval by members at a general meeting.
Also from Kronox Lab Sciences
PIT Reg 7(2) disclosures: promoters' sale of 9796400 shares each; acquirer acquired 2,38,44,000 shares (64.26%)
1 Oct 2026
Kronox Lab Sciences Ltd shareholder sells 18.10% stake, holding falls to 3.32%
30 Sep 2026
Kronox Lab Sciences Ltd shareholder sells 23.088% stake, holding falls to 3.32%
30 Sep 2026
More numbers
- Sale Shares transferred2,38,44,000 equity shares
- Stake sold as % of paid-up capital64.26%
- Sellers' residual holding36,90,000 equity shares
- Sellers' residual voting share capital9.95%
- Term of new directors' appointment5 years
- CFO appointment term5 (five) years
- Suresh Kalra - leadership experienceover 25 (twenty-five) years
- Sunil Malhotra - experience38 (thirty-eight) years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.